2016-03-11T00:00:00.000-05:00
cancer monitoring solutions,0.83198
pancreatic cancer,-0.636119
physicians,0.149832
important clinical information,0.611868
cancer patients,-0.215251
test,0.255262
billable samples,0.429662
health plan reimbursement,0.867151
cancer monitoring,0.111995
impressive clinical results,0.910292
liquid biopsy platform,0.63883
clinical utility,0.739141
non-small cell lung,-0.472608
question,0.137601
forward looking statements,0.327313
cancer types,0.272741
lung cancer application,-0.39784
little bit,0.194432
clinical study programs,0.526823
patient case studies,0.494547
clinical data,-0.0479331
health benefit plans,0.448108
clinical study results,0.624582
Stephen Zaniboni,0.267392
cell lung cancer,-0.484187
cancer monitoring services,-0.447653
clinical performance leadership,0.0841919
clinical experience program,0.40697
Matthew Posard,0.38931
clinical studies,0.357452
cancer monitoring platform,-0.106305
precision cancer,-0.035989
TrovaGene Research Institute,0.434106
tumor DNA,-0.0892428
clinical study,0.545059
major clinical oncology,0.362916
clinical study program,0.620088
Dan Leonard,0.240665
health insurance reimbursement,0.63172
good afternoon,0.671518
stage cancer patients,-0.518695
precision cancer monitoring,0.362916
cancer monitoring segments,-0.657142
